S100A4 and familial pancreatic carcinoma: Recent in vivo studies, including an orthotopic human pancreatic cancer xenograft mouse model, revealed that S100A4 activates focal adhesion kinase (FAK) and Src kinase, both involved in tumour progression and metastasis [184].